The "one-drug-fits-all" era of DMD treatment is officially over. Today, the most significant trend in the industry is the move toward multimodal therapy. Doctors are beginning to realize that while gene therapy can address the underlying genetic defect, the existing damage to muscle tissue and ongoing inflammation require additional interventions. We are entering a phase where a patient might...